SCHEMBL6129336

SCHEMBL6129336

CO[C@H]1O[C@H](COC(=O)CN)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ G6PD P11413 4/20 0.49
▸ PRKD3 O94806 1/20 0.49
▸ PRKCG P05129 1/20 0.49
▸ PRKCB P05771 1/20 0.49
▸ PRKCA P17252 1/20 0.49
▸ PRKCH P24723 1/20 0.49
▸ PRKCI P41743 1/20 0.49
▸ PRKCE Q02156 1/20 0.49
▸ PRKCQ Q04759 1/20 0.49
▸ PRKCZ Q05513 1/20 0.49
▸ PRKCD Q05655 1/20 0.49
▸ PRKD1 Q15139 1/20 0.49
▸ TLR4 O00206 1/20 0.46
▸ CA1 P00915 3/20 0.41
▸ CA2 P00918 3/20 0.41
▸ CA9 Q16790 3/20 0.41
▸ LGALS8 O00214 2/20 0.40
▸ IGF2R P11717 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29045687 0.83 LGALS8 (0.55) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL17253655 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL2320839 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL7150078 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL13752014 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL14175697 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL12038195 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL7146273 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL10291156 0.82 G6PD (0.46) G6PDPRKD3PRKCGPRKCBPRKCA
SCHEMBL28205738 0.82 PRKD3 (0.46) G6PDPRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944639-A4 SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL GLINSKII GUENNADI V (US) 2005-09-28 — — EP disclosed
WO-1999053930-A1 SYNTHETIC GLYCOAMINES AND METHODS FOR THEIR USE, ALONE OR IN COMBINATION WITH OTHER THERAPIES, THAT AFFECT CELL ADHESION, INHIBIT CANCER CELL GROWTH AND METASTASIS, AND INDUCE APOPTOSIS GLINSKII GUENNADI V (US) 1999-10-28 — — WO disclosed
EP-0944639-A1 SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL Glinskii, Guennadi, V. (US) 1999-09-29 — — EP disclosed
WO-1998023625-A9 SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL — 1998-09-17 — — WO disclosed
WO-1998023625-A1 SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL GLINSKII GUENNADI V (US) 1998-06-04 — — WO disclosed
Send feedback